Console & Associates P.C. Investigating Depo-Provera Injuries: Meningioma Brain Tumor Risks for Women Using Injectable Contraceptives

MARLTON, N.J., March 12, 2025 /PRNewswire/ -- A growing number of women who received Depo-Provera injections are coming forward with serious health concerns following new research linking the contraceptive drug to an increased risk of meningioma, a type of intracranial tumor. Many individuals who used progestogen-only injections such as Depo-Provera (DMPA, medroxyprogesterone acetate) for extended periods have reported symptoms such as chronic headaches, vision problems, dizziness, memory impairment, and seizures—common neurological symptoms associated with brain masses.

If you or a loved one developed a meningioma after long-term use of Depo-Provera, legal options may be available. However, due to strict statutes of limitations, those affected have only a limited window of time to take action. In some states, the statute of limitations for product liability cases is just one year from the date of injury or discovery. Console & Associates P.C. is reviewing cases for women who have been diagnosed with progesterone-induced meningiomas after prolonged use of this birth control injection.

What Is the Connection Between Depo-Provera and Meningiomas?

Depo-Provera is a progestin-based contraceptive shot used by millions worldwide for birth control, as well as for treating endometriosis, menstrual irregularities, and other hormonal conditions. However, a March 2024 study published in the British Medical Journal uncovered a troubling link. Researchers from France's National Agency for Medicines and Health Products Safety determined that prolonged use of medroxyprogesterone acetate (DMPA) increases the risk of developing meningiomas by five and a half times.

Meningiomas are intracranial tumors that form in the membranes surrounding the brain and spinal cord. While typically noncancerous, they can still cause severe neurological symptoms, including headaches, blurred vision, difficulty speaking, and cognitive impairment. Larger tumors may require surgery, radiation, or lifelong medical monitoring, posing significant health and financial burdens.

How Many Women Could Be at Risk?

Depo-Provera has been widely prescribed since its FDA approval in 1992, with millions of women worldwide using the contraceptive shot for birth control. In the United States alone, nearly 1.5 million women rely on Depo-Provera annually, according to the Guttmacher Institute. Given the newly identified risks of meningioma, a substantial number of women may have unknowingly developed progesterone-induced meningiomas after prolonged use.

Did Pfizer Fail to Warn About the Risks?

Despite growing concerns about the link between Depo-Provera and intracranial tumors, Pfizer—the drug's manufacturer—did not include this risk on its warning labels for decades. The company only recently acknowledged the potential danger, confirming plans to update patient information leaflets and product labels.

For years, women trusted Depo-Provera as a safe and effective birth control injection, unaware of the long-term health risks. Without clear warnings, many individuals lacked the information needed to make informed healthcare decisions. Now, countless women are left with neurological symptoms, permanent disabilities, and costly medical treatments—all of which could have been avoided had the manufacturer acted sooner.

Women who used Depo-Provera (DMPA, medroxyprogesterone acetate) for more than a year and were later diagnosed with meningiomas may have grounds for legal action. Lawsuits could seek compensation for medical expenses, lost wages, long-term care costs, and emotional distress.

What Are Your Legal Options If You Were Diagnosed with a Brain Tumor?

Those diagnosed with meningiomas after using Depo-Provera may qualify for a mass tort lawsuit, a type of legal action allowing multiple plaintiffs to hold the manufacturer accountable. Due to strict statutes of limitations, women affected by Depo-Provera birth control injection side effects must act quickly to protect their legal rights.

Console & Associates P.C. is currently evaluating claims for women who meet the following criteria:

• Used Depo-Provera (DMPA, medroxyprogesterone acetate) for one year or longer;
• Received a meningioma diagnosis; and
• Experienced headaches, blurred vision, seizures, memory loss, or other neurological symptoms

Many individuals facing a meningioma diagnosis require extensive medical treatments, including surgery, radiation therapy, or lifelong neurological monitoring. A successful lawsuit can provide the financial support necessary to cover these expenses, ensuring that those affected receive the care they need. However, holding Pfizer accountable is not just about compensation—it is about ensuring that pharmaceutical companies prioritize patient safety over profits.

The mass tort lawyers at Console & Associates, P.C. are dedicated to advocating on behalf of those injured by dangerous and defective drugs. Anyone interested in learning more about Depo-Provera Lawsuits should contact the firm for a no-obligation consultation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Console & Associates, P.C.
866-778-5500
[email protected]

SOURCE Console & Associates, P.C.